Home » Topics » BioWorld Science

BioWorld Science
RSS

Tsukushi protein mutations can lead to hydrocephalus

April 1, 2021

FDA approves Roszet to treat elevated LDL-C in primary nonfamilial hyperlipidemia and HoFH

April 1, 2021

Celon reports phase I data on second-generation GPR40 agonist CPL-280

April 1, 2021

U.S. approval for Sarclisa with Kd for relapsed or refractory multiple myeloma

April 1, 2021

Yingli reports phase II topline data on linperlisib in relapsed or refractory follicular lymphoma

April 1, 2021

China's NMPA approves Ayvakit for GIST with PDGFRA exon 18 mutation

April 1, 2021

Qinlock approved in China for advanced GIST

April 1, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

COMMD1 as therapeutic target and diagnostic biomarker in NSCLC

April 1, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents nuclear receptor ROR-gamma agonists

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...